Search results for "Pies"

showing 10 items of 510 documents

Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological c…

2022

Abstract Background The survival of patients with lung cancer has substantially increased in the last decade by about 15%. This increase is, basically, due to targeted therapies available for advanced stages and the emergence of immunotherapy itself. This work aims to study the situation of biomarker testing in Spain. Patients and methods The Thoracic Tumours Registry (TTR) is an observational, prospective, registry-based study that included patients diagnosed with lung cancer and other thoracic tumours, from September 2016 to 2020. This TTR study was sponsored by the Spanish Lung Cancer Group (GECP) Foundation, an independent, scientific, multidisciplinary oncology society that coordinates…

Cancer Research:Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms [DISEASES]Lung NeoplasmsTesting:Biological Factors::Biomarkers [CHEMICALS AND DRUGS]:factores biológicos::biomarcadores [COMPUESTOS QUÍMICOS Y DROGAS]Targeted therapiesPulmons - Càncer:neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares [ENFERMEDADES]Carcinoma Non-Small-Cell LungProto-Oncogene ProteinsGeneticsBiomarkers TumorHumansProspective StudiesCàncerDemographyReceptor Protein-Tyrosine KinasesProtein-Tyrosine KinasesErbB ReceptorsOncologySpainPulmonsMarcadors bioquímicsBiomarkersMetastatic lung cancer
researchProduct

MEF2C and SOCS2 in stemness regulation

2015

The physiologic stemness of hematopoietic stem cells (HSC) relies on mechanisms constitutively active under steady state and is fundamental to maintain a lifelong HSC reservoir. On the other side, similar stemness features sustained by partially overlapping molecular circuits, which have recently come into focus, confer aggressive aggressiveness in leukemia clones. Suppressor of Cytokine Signalling 2 (SOCS2) belongs to the SOCS family, comprising eight members (SOCS1–7 and CIS) with similar structures, which are induced upon JAK/STAT activation and function as negative regulators. Recent evidences have demonstrated that SOCS2 is endowed with immunological functions in differentiated cells b…

Cancer ResearchABLMyeloidCellular differentiationMyeloid leukemiaBiologymedicine.diseaseSuppressor of cytokine signallingHemergency hematopiesihemergency hematopiesisLeukemiaHaematopoiesisEditorialmedicine.anatomical_structureOncologymedicineCancer researchSOCS2Bone marrowHemergency hematopiesis; SOCS2; Cancer Research; OncologyOncoscience
researchProduct

Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment†

2020

### Highlights There is no clear definition of orphan symptoms. There is a group of symptoms that are seldom evaluated in most symptom assessment tools which can be considered as orphan symptoms.1 These are generally prevalent symptoms that are unaddressed in clinical practice, yet often not reported by the patients or by healthcare professionals.2 Orphan symptoms may be defined as symptoms not regularly assessed in clinical practice, and consequently little studied and not properly treated. No epidemiological or clinical studies generally exist to gauge the prevalence of the symptoms chosen; nevertheless, these symptoms are distressing for patients and their families. Orphan symptoms remai…

Cancer ResearchPediatricsmedicine.medical_specialtydiagnosisoncological therapiesMEDLINElcsh:RC254-282Quality of lifeEpidemiologymedicine1506Restless legs syndromeOriginal Researchtreatmentbusiness.industryEvidence-based medicineorphan symptomsmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensRectal tenesmusclinical practice guidelines; diagnosis; oncological therapies; orphan symptoms; treatmentOncologymedicine.symptombusinessMyoclonusclinical practice guidelinesMuscle crampESMO Open
researchProduct

Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI…

2021

ROMEI, a prospective, observational study in patients with myelofibrosis receiving the oral JAK1/2 inhibitor ruxolitinib in real-world practice, assesses treatment adherence based on the 8-item Morisky Medication Adherence Scale (MMAS-8). Here, we present MMAS-8 results at week 24. Overall, 101 of 188 evaluable patients completed the questionnaire at every visit (full completers). Mean (±standard deviation) total MMAS-8 scores remained stable from week 4 to week 24 in the overall population (7.54 ± 0.77 and 7.67 ± 0.70, respectively) and full completers (7.53 ± 0.79 and 7.67 ± 0.73, respectively). Rates of low (MMAS-8 ˂6) or medium (MMAS-8 ≥ 6 to ˂8) adherence were 25–40% and 26–36%, respec…

Cancer Researchmedicine.medical_specialtyRuxolitinib8-item Morisky Medication Adherence ScalePsychometricsTreatment adherenceruxolitiniboral therapiesMedication AdherenceCohort StudiesTreatment complianceInternal medicineSurveys and QuestionnairesNitrilesmedicineHumansIn patientProspective StudiesProspective cohort studyMyelofibrosistreatment compliance8-item Morisky Medication Adherence Scale oral therapies ruxolitinib treatment compliance Adherencebusiness.industryHematologyJanus Kinase 1Janus Kinase 2Interim analysismedicine.disease8-item Morisky Medication Adherence Scale; Adherence; oral therapies; ruxolitinib; treatment compliancePyrimidinesOncologyAdherencePrimary MyelofibrosisPyrazolesObservational studybusinessmedicine.drugLeukemialymphoma
researchProduct

Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development.

2020

Shared-decision making for head and neck squamous cell carcinoma (HNSCC) is challenged by the difficulty to integrate the patient perception of value within the framework of a multidisciplinary team approach. The aim of this study was to develop a questionnaire to assess the preferences of HNSCC patients with respect to the disease trajectory, expected treatment, and toxicities. In accordance with the standardized EORTC Quality of Life Group&rsquo

Cancer Researchmedicine.medical_specialtyScoring criteriaDiseaselcsh:RC254-282Article03 medical and health sciences0302 clinical medicineQuality of lifehead and neck cancer; multimodal therapies; patient preferences; patient priorities; quality of lifeHealth caremedicineIn patient030212 general & internal medicinemultimodal therapiesneoplasmsbusiness.industryHead and neck cancermedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensHead and neck squamous-cell carcinoma3. Good healthstomatognathic diseasesPatient perceptionsOncologypatient prioritiesquality of life030220 oncology & carcinogenesisFamily medicinehead and neck cancerbusinesspatient preferences
researchProduct

Benvingut Rogers a Espanya o de què tracta, realment, l'empatia

2016

espanolEl objetivo de este trabajo es aportar una vision global de la obra de Carl Rogers y de su impacto en el panorama internacional y espanol de la Psicoterapia actual. Planteamos que la obra de Rogers y el concepto de empatia no han «entrado» realmente en Espana, que el conocimiento que aqui existe es superficial y anecdotico, comparado con el desarrollo e impacto internacional que tienen hoy. Para mostrarlo, se evalua la presencia de la obra de Rogers en nuestro contexto geografico, aplicando algunos indices de prevalencia utilizados en anteriores revisiones internacionales: a) publicaciones que existen sobre Rogers o su obra; b) organizaciones profesionales, Institutos de Formacion y …

Carl Rogers empatia teràpies experiencials. Artículo:PSICOLOGÍA [UNESCO]General Earth and Planetary SciencesUNESCO::PSICOLOGÍAGeneral Environmental ScienceAnuari de Psicologia de la Societat Valenciana de Psicologia
researchProduct

Circular dichroism of polynucleotides: Interactions of NiCl2 with poly(dA-dT).poly(dA-dT) and poly(dG-dC).poly(dG-dC) in a water-in-oil microemulsion.

2008

The thermal behavior of the synthetic, high molecular weight, double stranded polynucleotides poly(dA-dT)·poly(dA-dT) [polyAT] and poly(dG-dC)·poly(dG-dC) [polyGC] solubilized in the aqueous core of the quaternary water-in-oil cationic microemulsion CTAB|n-pentanol|n-hexane|water in the presence of increasing amounts of NiCl2 at several constant ionic strength values (NaCl) has been studied by means of circular dichroism and electronic absorption spectroscopies. In the microemulsive medium, both polynucleotides show temperature-induced modifications that markedly vary with both Ni(II) concentration and ionic strength. An increase of temperature causes denaturation of the polyAT duplex at lo…

Circular dichroismPolynucleotidesAnalytical chemistryIonic bondingchemistry.chemical_elementmodel polynucleotideCatalysisAnalytical ChemistryNickelthermal denaturationDrug DiscoveryMicroemulsionSpectroscopyPharmacologyAqueous solutionChemistryCircular DichroismOrganic ChemistryCationic polymerizationTemperatureWaterCD and UV spectroscopiesnickel (II) ionNickelCrystallographywater-in-oil microemulsionPolynucleotideIonic strengthEmulsionsOilsChirality
researchProduct

The use of complementary therapies for chronic pain in Italian hospices.

2013

Scopo: Sebbene ci sia un incremento dell’utilizzo delle Terapie Complemntari (CT) in Europa, ancora è poco noto l’utilizzo di esse negli hospice italiani per il trattamento del dolore cronico. Questa indagine ha lo scopo di descrivere la diffusione delle CT e le loro diverse tipologie impiegate per il trattamento del dolore cronico nel setting assistenziale delle Cure Palliative. Metodi. È stata realizzata una indagine on-line su tutto il campione dei 16 hospices presenti nel territorio della Regione Lazio, utilizzando un questionario adattato e validato per descriverne utilizzo e barriere dell’uso delle CT per il trattamento del dolore cronico oncologico e benigno. Risultati: Il tasso di r…

Complementary TherapiesHospice CareItalyhospices; chronic pain; pain management; humans; hospice care; italy; complementary therapiesPalliative careHospicesHumansPain ManagementNursingComplementary TherapyChronic PainSettore MED/45 - Scienze Infermieristiche Generali Cliniche E Pediatriche
researchProduct

Alternative and complementary therapies in osteoarthritis and cartilage repair

2020

Osteoarthritis (OA) is the most common joint condition and, with a burgeoning ageing population, is due to increase in prevalence. Beyond conventional medical and surgical interventions, there are an increasing number of ‘alternative’ therapies. These alternative therapies may have a limited evidence base and, for this reason, are often only afforded brief reference (or completely excluded) from current OA guidelines. Thus, the aim of this review was to synthesize the current evidence regarding autologous chondrocyte implantation (ACI), mesenchymal stem cell (MSC) therapy, platelet-rich plasma (PRP), vitamin D and other alternative therapies. The majority of studies were in knee OA or chond…

Complementary TherapiesMaleAgingmedicine.medical_specialtyAlternativeMEDLINEPsychological interventionOsteoarthritisReviewPlaceboMesenchymal Stem Cell TransplantationTransplantation Autologous03 medical and health sciences0302 clinical medicineChondrocytesOsteoarthritismedicineVitamin D and neurologyHumansVitamin DIntensive care medicineAutologous chondrocyte implantationddc:616030203 arthritis & rheumatology030222 orthopedicsbusiness.industryCartilageAge FactorsOsteoarthritis Cartilage Alternative Therapy Treatment HerbalVitaminsOsteoarthritis Kneemedicine.diseaseClinical trialTreatmentmedicine.anatomical_structureCartilageTreatment OutcomeHerbalFemaleTherapyGeriatrics and GerontologybusinessAging Clinical and Experimental Research
researchProduct

Complementary and alternative treatment methods in children with cancer: A population-based retrospective survey on the prevalence of use in Germany.

2008

Abstract Introduction Few studies have been conducted to date on the prevalence of use of complementary and alternative treatment methods (CAMs) in paediatric oncology, and those that have been conducted are often not representative. We therefore decided to study a representative sample of children with cancer in the German population. Patients and methods The study took the form of a retrospective survey amongst all parents whose children were first diagnosed with a disease covered by the German Childhood Cancer Registry in 2001. The primary objectives of the survey were to establish the prevalence of use of CAM and the factors related to its use. Results Of the 1595 questionnaires sent ou…

Complementary TherapiesMaleParentsCancer Researchmedicine.medical_specialtyPediatricsmedicine.medical_treatmentAlternative medicineMEDLINEDiseaseAnthroposophic medicineGermanyNeoplasmsEpidemiologymedicineHumansChildRetrospective StudiesChildhood Cancer Registrybusiness.industryInfant NewbornInfantRetrospective cohort studyHomeopathyOncologySocioeconomic FactorsFamily medicineChild PreschoolHealth Care SurveysFemalebusinessAttitude to HealthEuropean journal of cancer (Oxford, England : 1990)
researchProduct